Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm Syndrome

CompletedOBSERVATIONAL
Enrollment

9,984

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

September 30, 2004

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Meloxicam

DRUG

Other Non Steroidal Anti-Inflammatory Drugs (NSAIDs) except etodolac

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY